Lobbes H, Reynaud Q, Mainbourg S, Lega J C, Durieu I, Durupt S
Service de Médecine Interne, Hôpital Estaing, CHU de Clermont-Ferrand, 1 Place Lucie et Raymond Aubrac, 63000 Clermont-Ferrand, France; Service de Médecine Interne et Vasculaire, Hôpital Lyon Sud, Hospices Civils de Lyon, 165 Chemin du grand Revoyet, 69310 Pierre-Bénite, France.
Service de Médecine Interne et Vasculaire, Hôpital Lyon Sud, Hospices Civils de Lyon, 165 Chemin du grand Revoyet, 69310 Pierre-Bénite, France.
Rev Med Interne. 2020 Nov;41(11):748-755. doi: 10.1016/j.revmed.2020.06.006. Epub 2020 Jul 23.
Tryptase is the most abundant endopeptidase released by mast cells degranulation, involved in many pro and anti-inflammatory processes. Normal serum tryptase range is 0-11.4 μg/L. Tryptase is a useful diagnostic tool for anaphylaxis, systemic mastocytosis (SM) and mast cell activation syndrome (MCAS), where specific threshold values must be used. SM diagnosis criteria include evidence of dense mast cell infiltrate either in the bone marrow or the affected organ (such as skin), presence of KIT D816V mutation and elevated serum tryptase level (>20 μg/L). In SM, tryptase level is correlated with the burden of mast cells in bone marrow. MCAS should be considered in case of severe and recurrent typical clinical signs of systemic mast cell activation involving at least two organs, associated with an increase in serum tryptase level of 20% + 2 μg/L from the individual's baseline. Anaphylaxis is the most severe among hypersensitivity reactions. A clonal mast cell disorder is a central question in anaphylaxis and appropriate explorations should be conducted in these patients. Triggers for anaphylactic reactions vary significantly in the general population and in patients with MS or MCAS. Finally, physicians must be aware of the many pathological and physiological situations that affect tryptase levels.
类胰蛋白酶是肥大细胞脱颗粒释放的最丰富的内肽酶,参与许多促炎和抗炎过程。正常血清类胰蛋白酶范围是0 - 11.4μg/L。类胰蛋白酶是过敏反应、系统性肥大细胞增多症(SM)和肥大细胞活化综合征(MCAS)的一种有用的诊断工具,在这些病症中必须使用特定的阈值。SM的诊断标准包括骨髓或受累器官(如皮肤)中密集肥大细胞浸润的证据、KIT D816V突变的存在以及血清类胰蛋白酶水平升高(>20μg/L)。在SM中,类胰蛋白酶水平与骨髓中肥大细胞的负荷相关。如果出现涉及至少两个器官的严重且复发性的典型全身肥大细胞活化临床症状,且血清类胰蛋白酶水平比个体基线升高20% + 2μg/L,则应考虑MCAS。过敏反应是超敏反应中最严重的。克隆性肥大细胞疾病是过敏反应中的一个核心问题,应对这些患者进行适当的检查。过敏反应的触发因素在普通人群以及患有MS或MCAS的患者中差异很大。最后,医生必须了解影响类胰蛋白酶水平的许多病理和生理情况。